Welcome to the Hepatitis B Therapeutics Summit
Focus on Community Perspectives and Clinical Trial Diversity
We invite you to join us on Oct. 7 for an unprecedented gathering of industry leaders, scientists and advocates at the Hepatitis B Therapeutics Summit: a unique platform dedicated to advancing hepatitis B therapeutics research, fostering collaboration and promoting diversity in clinical trials.
This is the first-ever summit dedicated to patient perspectives surrounding hepatitis B treatment and clinical trials. The full-day program will focus on in-depth discussions on the most pressing treatment-related wants and needs of people living with hepatitis B and explore patient-focused outcomes related to treatment and clinical trials.
Join industry, academic, public health and nonprofit leaders, and people with lived experience, for a day of presentations, interactive discussions and networking. Participants will take away actionable insights for implementing patient-focused drug and clinical trial development. This summit is ideal for all stakeholders involved in drug and clinical trial development.
To download a PDF of the summit's agenda, please click here.
Why attend?
Community Perspectives
At the heart of our summit lies a commitment to amplifying community voices. This is an opportunity to gain invaluable insights from people living with hepatitis B and to help shape the future of hepatitis B drug and clinical trial development.
​
Clinical Trial Diversity
Diversity is critical to the future success of hepatitis B clinical trials. We will hear from multi-sectoral stakeholders, including the FDA, and explore strategies to enhance diversity and inclusion in clinical trials, ensuring that treatments are effective and accessible to all populations affected by hepatitis B.
Networking Opportunities
This is a chance to forge meaningful connections with researchers, leaders
and advocates.​
Impactful Discussions
Participate in dynamic panel discussions, workshops and interactive sessions designed to exchange ideas and lead to actionable strategies for creation of patient-focused, diverse-minded therapeutic strategies and clinical trials.
*Nonprofit researchers interested in attending should reach out directly to HBVsummit@hepb.org for additional information on pricing.
Session Topics
Improving Clinical Diversity for Hepatitis B,
FDA Perspective
Lived Experiences Panel
Clinical Trial Endpoints: Integrating Quality of Life Indicators and Patient Reported Outcomes
Patient Perspectives on Future Hepatitis B Treatment, U.S. and Global
Patient Perspectives on Clinical Trials, U.S. and Global
Improving Clinical Trial Participation and Diversity: Panel Session
Visiting Philadelphia
The conference will be held at CYTOPHL in the heart of the city at 2929 Arch Street, Philadelphia.